Diabetes

February 14, 2018

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Pantoprazole increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 14/February/2018, 6.08 am

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Pantoprazole increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 14/February/2018, 6.08 am https://genomediscovery.org/wp-content/uploads/2018/02/A-pharmaceutical-mixture-encompassing-Pyridoxamin-and-Pantoprazole-acts-as-an-anti-diabetic-agent-by-increasing-Pax6-expression.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/A-pharmaceutical-mixture-encompassing-Pyridoxamin-and-Pantoprazole-acts-as-an-anti-diabetic-agent-by-increasing-Pax6-expression.jpg February 14, 2018 February 14, 2018

Introduction: What they say A study from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada, The Hebrew University-Hadassah Medical School, Jerusalem, Israel shows that…

February 14, 2018

Amino acid-based therapy for autoimmune diabetes (TIDM): Taurine (2-aminoethanesulfonic acid) increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 14/February/2018, 5.54 am

Amino acid-based therapy for autoimmune diabetes (TIDM): Taurine (2-aminoethanesulfonic acid) increases PD-L1 expression, increases Tregs function, promotes immune tolerance, increases pancreatic β-cell proliferation and regeneration, increases insulin secretion, improves insulin sensitivity, increases energy utilization, and reverses TIDM, via up regulation of its target gene, 14/February/2018, 5.54 am https://genomediscovery.org/wp-content/uploads/2018/02/Taurine-may-protect-against-autoimmune-diabetes-T1DM-through-up-regulation-of-PD-L1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Taurine-may-protect-against-autoimmune-diabetes-T1DM-through-up-regulation-of-PD-L1.jpg February 14, 2018 February 14, 2018

Introduction: What they say A study from the International Center for T1D, Pediatric Clinical Research Center Romeo ed Enrica Invernizzi, “L. Sacco” Department of Biomedical and Clinical Sciences, University of…

February 12, 2018

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and D-3-Hydroxybutyrate (PMD3HB) increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 13/February/2018, 12.29 am

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and D-3-Hydroxybutyrate (PMD3HB) increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 13/February/2018, 12.29 am https://genomediscovery.org/wp-content/uploads/2018/02/A-1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/A-1.jpg February 12, 2018 February 12, 2018

February 11, 2018

Natural product-based therapy for diabetes (TIDM): Puerarin, isolated from Kudju or Puraria Montana, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 12/February/2018,12.43 am

Natural product-based therapy for diabetes (TIDM): Puerarin, isolated from Kudju or Puraria Montana, increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 12/February/2018,12.43 am https://genomediscovery.org/wp-content/uploads/2018/02/Puerarin-increases-Caveolin1-CAV1-and-GLP1Rexp-augments-insulin-secretion-and-sensitivity-attenuates-the-development-of-diabetes.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Puerarin-increases-Caveolin1-CAV1-and-GLP1Rexp-augments-insulin-secretion-and-sensitivity-attenuates-the-development-of-diabetes.jpg February 11, 2018 February 11, 2018

Introduction: What they say A study from the Comprehensive Diabetes Center and Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Alabama at Birmingham, Birmingham, AL shows that…

February 11, 2018

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Hydralazine (PMHL) increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 11/February/2018, 11.34 pm

Vitamin-based therapy for glucose homeostasis and TIIDM: A pharmaceutical mixture encompassing Pyridoxamine and Hydralazine (PMHL) increases Pax6 and insulin expression, decreases the levels of glucagon, ghrelin and Somatostatin, reduces metabolic stress, improves insulin sensitivity, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 11/February/2018, 11.34 pm https://genomediscovery.org/wp-content/uploads/2018/02/A.jpg4_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/A.jpg4_.jpg February 11, 2018 February 11, 2018

February 10, 2018

Amino acid-based therapy for diabetes (TIDM): Taurine (2-aminoethanesulfonic acid) increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 10/February/2017,11.00 am

Amino acid-based therapy for diabetes (TIDM): Taurine (2-aminoethanesulfonic acid) increases GLP1R and Caveolin-1 (CAV-1) expression, promotes glucose-induced insulin secretion, improves insulin sensitivity, increases energy utilization, promotes weight loss and protects from diet-induced obesity and TIIDM via up regulation of its target gene, 10/February/2017,11.00 am https://genomediscovery.org/wp-content/uploads/2018/02/Taurine-increases-Caveolin1-CAV1-and-GLP1R-augments-insulin-secretion-and-sensitivity-and-attenuates-the-development-of-diabetes1.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Taurine-increases-Caveolin1-CAV1-and-GLP1R-augments-insulin-secretion-and-sensitivity-and-attenuates-the-development-of-diabetes1.jpg February 10, 2018 February 10, 2018

Popular Post